MGNX

Chhabra Meenu

Known title: DirectorCIK: 0001534200

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 27, 2026

MGNX mentioned in medical stock sector review. MacroGenics was included in a recent Yahoo Finance article examining the performance of medical stocks this year. The stock is currently trading near its 52-week low, with technical indicators showing weakness near key support levels. This context highlights the broader sector trends affecting the company's valuation.

this person other insiders at MGNX

Transaction History

MGNX▲ Buy—
MGNX▲ Buy—
MGNX▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.